Investing.com -- Rezolute, Inc. (NASDAQ:RZLT) stock fell 90% after the company announced that its Phase 3 sunRIZE study evaluating ersodetug in patients with congenital hyperinsulinism did not meet ...

Investing.com -- Hungary will continue its price margin restrictions on food and drugstore products despite opposition from the European Union, according to a statement released by the country’s ...

Bulgarian Prime Minister Rosen Zhelyazkov submitted his government’s resignation on Thursday following weeks of street demonstrations against his administration ...

Oxford Industries (NYSE:OXM) stock slumped 22% after the apparel company, which owns brands such as Tommy Bahama and Lilly Pulitzer, cut its earnings forecast for the full year, citing a "softer than ...

Hitting sentiment Thursday was disappointing news from Oracle (NYSE:ORCL), as the cloud computing firm sharply hiked its ...

Manchester United reiterated its full-year fiscal 2026 guidance of £640 million to £660 million in revenue and adjusted EBITDA of £180 million to £200 million. The men’s first team is currently ...

The private equity firm’s decision to further decrease its stake in the company comes amid a period of significant trading activity in Coherent shares. This latest unregistered block trade follows two ...

US index futures fell back in early trade on Thursday as Oracle (NYSE:ORCL) reignited unease over the scale of AI spending. This comes just a day after the Fed’s rate cut, in a meeting that was deemed ...

Kepler Cheuvreux maintained a positive stance on European semiconductor companies, naming Besi, Infineon and Nordic Semiconductor as its most preferred stocks in ...

The partnership will place AXIL’s new X30 LT in-ear hearing protection plugs in over 3,700 Walmart stores nationwide, with the launch expected in February 2026. This represents the company’s largest ...

Labor unions in Japan have recently suggested that they will focus on securing bumper pay hikes in 2026. Rengo, the country’s ...

Investing.com -- AC Immune (NASDAQ:ACIU) stock rose 25% after the company reported positive interim Phase 2 data for its Parkinson’s disease treatment, suggesting the therapy may slow disease ...